What is the proper dosing for intravenous (IV) iron?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Iron Dosing Guidelines

For patients with iron deficiency anemia, IV iron should be dosed according to patient-specific factors including weight, severity of anemia, and clinical setting, with hemodialysis patients typically receiving 100 mg per dose and non-dialysis patients receiving larger single doses of 500-1000 mg to reduce healthcare visits. 1

Adult Dosing by Clinical Setting

Hemodialysis Patients

  • In-center hemodialysis patients:

    • 100 mg iron dextran IV per dialysis session (given as IV push over 2 minutes)
    • Total cumulative dose: 1000 mg (typically over 10 sessions)
    • This smaller dosing minimizes dose-related arthralgias/myalgias 1
  • For ferric sodium gluconate (Ferrlecit):

    • 125 mg elemental iron (10 mL) per dialysis session
    • Dilute in 100 mL of 0.9% sodium chloride and infuse over 1 hour
    • Or administer undiluted as slow IV injection (up to 12.5 mg/min)
    • Most patients require cumulative dose of 1000 mg over 8 dialysis sessions 2

Home Hemodialysis, Peritoneal Dialysis, or CKD Patients

  • Single larger doses:
    • 500-1000 mg iron dextran diluted in 250 mL normal saline
    • Infuse over 1 hour
    • Repeat as necessary to maintain adequate iron stores
    • Patients should be informed of increased risk of myalgias/arthralgias with larger doses 1

Cancer-Related Anemia

  • Typical dosing regimens:
    • 750-2000 mg total dose
    • Common regimens: 125-400 mg weekly or every 3 weeks 1
    • Consider IV iron for patients with TSAT <20% 1

Inflammatory Bowel Disease

  • Simplified dosing scheme based on weight and hemoglobin:
Hemoglobin g/dL Body weight <70 kg Body weight ≥70 kg
10-12 [women] 10-13 [men] 1000 mg 1500 mg
7-10 1500 mg 2000 mg
  • First-line treatment for patients with clinically active IBD, previous intolerance to oral iron, or hemoglobin below 10 g/dL 1

Pediatric Dosing

Pediatric Hemodialysis Patients

Iron dextran dosing per session in a 10-dose course:

  • Weight <10 kg: 25 mg (0.5 mL)
  • Weight 10-20 kg: 50 mg (1.0 mL)
  • Weight >20 kg: 100 mg (2.0 mL) 1

Pediatric Predialysis and PD Patients

Single dose of iron dextran:

  • Weight <10 kg: 125 mg in 75 mL saline
  • Weight 10-20 kg: 250 mg in 125 mL saline
  • Weight >20 kg: 500 mg in 250 mL saline 1

Ferric Gluconate in Pediatric Patients

  • 0.12 mL/kg (1.5 mg/kg elemental iron)
  • Dilute in 25 mL 0.9% sodium chloride
  • Administer by IV infusion over 1 hour per dialysis session
  • Maximum dose: 125 mg per dose 2

Monitoring Parameters

  • Measure TSAT and serum ferritin 2-7 days after last dose of IV iron

    • For doses of 100-125 mg, wait at least 7 days
    • For doses >1000 mg, wait at least 14 days 1
  • Target parameters:

    • TSAT ≥20%
    • Serum ferritin ≥100 ng/mL
    • Hemoglobin 11-12 g/dL 1
  • Monitor for iron overload:

    • Avoid IV iron if TSAT >50% or ferritin >800 μg/L 1
    • Regular monitoring of hematologic and iron parameters is required 2

Safety Considerations

  1. Hypersensitivity reactions:

    • Monitor patients for at least 30 minutes after administration
    • Have personnel and therapies available for treating anaphylaxis 2
  2. Hypotension:

    • May occur during or after administration
    • Monitor vital signs during and after infusion 2
  3. Test dose:

    • Required for iron dextran preparations due to risk of anaphylactic reactions
    • Not required for newer preparations like ferric carboxymaltose, iron sucrose, or ferric gluconate 1
  4. Avoid in iron overload:

    • Do not administer to patients with evidence of iron overload 2

Practical Considerations

  • Recent research suggests that the actual iron deficit in most patients with iron deficiency anemia is closer to 1500 mg rather than the traditional 1000 mg 3
  • Lower retreatment rates (5.6% vs 11.1%) were observed with 1500 mg cumulative dose compared to 1000 mg 3
  • For maintenance therapy in hemodialysis patients, provide 250-1000 mg of iron within 12 weeks 1
  • Oral iron is not recommended when IV iron is required due to inconvenience, cost, and side effects 1

IV iron administration should be tailored to the specific clinical scenario, with appropriate monitoring for efficacy and safety to optimize outcomes related to morbidity, mortality, and quality of life.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.